CA Stock MarketDetailed Quotes

MDMA Pharmala Biotech Holdings Inc

Watchlist
  • 0.320
  • +0.025+8.47%
15min DelayMarket Closed Nov 25 15:59 ET
30.85MMarket Cap-40000P/E (TTM)

Pharmala Biotech Holdings Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
(Q3)May 31, 2022
Total revenue
-3.13%90.42K
752.47K
581.44%532K
5,712.48%438.67K
0
93.34K
0
78.07K
7.55K
70.52K
Operating revenue
-3.13%90.42K
--752.47K
581.44%532K
5,712.48%438.67K
--0
--93.34K
--0
--78.07K
--7.55K
--70.52K
Cost of revenue
0
292.96K
3,304.90%77.9K
17,850.23%77.9K
0
0
0
2.29K
434
1.85K
Gross profit
-3.13%90.42K
459.51K
499.22%454.1K
4,971.90%360.76K
0
93.34K
0
75.78K
7.11K
68.67K
Operating expense
0.57%312.99K
-12.10%253.61K
14.67%1.22M
36.87%271.77K
23.29%338.74K
9.07%311.22K
-4.70%288.5K
-57.70%1.06M
198.56K
-88.14%274.75K
Selling and administrative expenses
-2.72%236.42K
-28.62%176.99K
25.46%1.15M
115.49%354.24K
17.17%300.07K
-3.59%243.03K
0.90%247.95K
-62.81%918.28K
--164.39K
-88.86%256.09K
-General and administrative expense
-2.72%236.42K
-28.62%176.99K
25.46%1.15M
115.49%354.24K
17.17%300.07K
-3.59%243.03K
0.90%247.95K
-62.81%918.28K
--164.39K
-88.86%256.09K
Research and development costs
--32.17K
--41.67K
---166.52K
----
----
--0
--0
--0
----
----
Depreciation amortization depletion
19.72%15.78K
19.84%15.79K
334.82%52.77K
20.37%13.23K
2,861.35%13.18K
2,861.35%13.18K
5,108.70%13.18K
3,904.95%12.14K
--10.99K
340.59%445
-Depreciation and amortization
19.72%15.78K
19.84%15.79K
334.82%52.77K
20.37%13.23K
2,861.35%13.18K
2,861.35%13.18K
5,108.70%13.18K
3,904.95%12.14K
--10.99K
340.59%445
Other operating expenses
-47.98%28.62K
-30.03%19.16K
36.47%178.71K
205.52%70.82K
39.96%25.5K
67.63%55.01K
-51.75%27.38K
230.66%130.95K
--23.18K
-4.87%18.22K
Operating profit
-2.15%-222.57K
171.37%205.91K
22.59%-762.95K
146.49%89K
-64.37%-338.74K
23.64%-217.89K
4.70%-288.5K
60.72%-985.58K
-191.45K
91.11%-206.08K
Net non-operating interest income (expenses)
Other net income (expenses)
-169.43K
-16.86K
-169.3K
145.62K
Special income (charges)
----
----
---16.86K
----
----
----
----
--0
----
----
-Less:Write off
----
----
--16.86K
----
----
----
----
--0
----
----
Other non-operating income (expenses)
----
---169.43K
----
----
----
--145.62K
----
----
----
----
Income before tax
-207.97%-222.57K
112.64%36.48K
20.88%-779.81K
58.06%-80.3K
-64.37%-338.74K
74.67%-72.27K
4.70%-288.5K
60.72%-985.58K
-191.45K
91.11%-206.08K
Income tax
Earnings from equity interest net of tax
Net income
-207.97%-222.57K
112.64%36.48K
20.88%-779.81K
58.06%-80.3K
-64.37%-338.74K
74.67%-72.27K
4.70%-288.5K
60.72%-985.58K
-191.45K
91.11%-206.08K
Net income continuous operations
-207.97%-222.57K
112.64%36.48K
20.88%-779.81K
58.06%-80.3K
-64.37%-338.74K
74.67%-72.27K
4.70%-288.5K
60.72%-985.58K
---191.45K
91.11%-206.08K
Noncontrolling interests
Net income attributable to the company
-207.97%-222.57K
112.64%36.48K
20.88%-779.81K
58.06%-80.3K
-64.37%-338.74K
74.67%-72.27K
4.70%-288.5K
60.72%-985.58K
-191.45K
91.11%-206.08K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-207.97%-222.57K
112.64%36.48K
20.88%-779.81K
58.06%-80.3K
-64.37%-338.74K
74.67%-72.27K
4.70%-288.5K
60.72%-985.58K
-191.45K
91.11%-206.08K
Diluted earnings per share
-194.03%-0.0026
112.14%0.0004
0.00%-0.01
0
-64.36%-0.0041
74.67%-0.0009
4.69%-0.0035
66.92%-0.01
0
91.11%-0.0025
Basic earnings per share
-194.03%-0.0026
112.14%0.0004
0.00%-0.01
0
-64.36%-0.0041
74.67%-0.0009
4.69%-0.0035
66.92%-0.01
0
91.11%-0.0025
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022(Q3)May 31, 2022
Total revenue -3.13%90.42K752.47K581.44%532K5,712.48%438.67K093.34K078.07K7.55K70.52K
Operating revenue -3.13%90.42K--752.47K581.44%532K5,712.48%438.67K--0--93.34K--0--78.07K--7.55K--70.52K
Cost of revenue 0292.96K3,304.90%77.9K17,850.23%77.9K0002.29K4341.85K
Gross profit -3.13%90.42K459.51K499.22%454.1K4,971.90%360.76K093.34K075.78K7.11K68.67K
Operating expense 0.57%312.99K-12.10%253.61K14.67%1.22M36.87%271.77K23.29%338.74K9.07%311.22K-4.70%288.5K-57.70%1.06M198.56K-88.14%274.75K
Selling and administrative expenses -2.72%236.42K-28.62%176.99K25.46%1.15M115.49%354.24K17.17%300.07K-3.59%243.03K0.90%247.95K-62.81%918.28K--164.39K-88.86%256.09K
-General and administrative expense -2.72%236.42K-28.62%176.99K25.46%1.15M115.49%354.24K17.17%300.07K-3.59%243.03K0.90%247.95K-62.81%918.28K--164.39K-88.86%256.09K
Research and development costs --32.17K--41.67K---166.52K----------0--0--0--------
Depreciation amortization depletion 19.72%15.78K19.84%15.79K334.82%52.77K20.37%13.23K2,861.35%13.18K2,861.35%13.18K5,108.70%13.18K3,904.95%12.14K--10.99K340.59%445
-Depreciation and amortization 19.72%15.78K19.84%15.79K334.82%52.77K20.37%13.23K2,861.35%13.18K2,861.35%13.18K5,108.70%13.18K3,904.95%12.14K--10.99K340.59%445
Other operating expenses -47.98%28.62K-30.03%19.16K36.47%178.71K205.52%70.82K39.96%25.5K67.63%55.01K-51.75%27.38K230.66%130.95K--23.18K-4.87%18.22K
Operating profit -2.15%-222.57K171.37%205.91K22.59%-762.95K146.49%89K-64.37%-338.74K23.64%-217.89K4.70%-288.5K60.72%-985.58K-191.45K91.11%-206.08K
Net non-operating interest income (expenses)
Other net income (expenses) -169.43K-16.86K-169.3K145.62K
Special income (charges) -----------16.86K------------------0--------
-Less:Write off ----------16.86K------------------0--------
Other non-operating income (expenses) -------169.43K--------------145.62K----------------
Income before tax -207.97%-222.57K112.64%36.48K20.88%-779.81K58.06%-80.3K-64.37%-338.74K74.67%-72.27K4.70%-288.5K60.72%-985.58K-191.45K91.11%-206.08K
Income tax
Earnings from equity interest net of tax
Net income -207.97%-222.57K112.64%36.48K20.88%-779.81K58.06%-80.3K-64.37%-338.74K74.67%-72.27K4.70%-288.5K60.72%-985.58K-191.45K91.11%-206.08K
Net income continuous operations -207.97%-222.57K112.64%36.48K20.88%-779.81K58.06%-80.3K-64.37%-338.74K74.67%-72.27K4.70%-288.5K60.72%-985.58K---191.45K91.11%-206.08K
Noncontrolling interests
Net income attributable to the company -207.97%-222.57K112.64%36.48K20.88%-779.81K58.06%-80.3K-64.37%-338.74K74.67%-72.27K4.70%-288.5K60.72%-985.58K-191.45K91.11%-206.08K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -207.97%-222.57K112.64%36.48K20.88%-779.81K58.06%-80.3K-64.37%-338.74K74.67%-72.27K4.70%-288.5K60.72%-985.58K-191.45K91.11%-206.08K
Diluted earnings per share -194.03%-0.0026112.14%0.00040.00%-0.010-64.36%-0.004174.67%-0.00094.69%-0.003566.92%-0.01091.11%-0.0025
Basic earnings per share -194.03%-0.0026112.14%0.00040.00%-0.010-64.36%-0.004174.67%-0.00094.69%-0.003566.92%-0.01091.11%-0.0025
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data